The same inhibitory effect could also be seen in TNF-α-activated fibroblasts treated with zerumbone, in which tumor-promoting cytokines TNF-α, TGF-β, IL-33, SDF-1, and MCP-1 were significantly reduced in comparison to TNF-α-activated fibroblasts [144]. The gene discussed is CCL2; the disease is neoplasm.